title: Electrophysiological changes in diabetic neuropathy: from subclinical alterations to disabling abnormalities.
abstract: Clinical spectrum of diabetic neuropathy is variable; it may be asymptomatic, but once established as polyneuropathy, it is irreversible and may finally be disabling. To estimate the prevalence of subclinical diabetic polyneuropathy in the UAE, we undertook a pilot study by means of nerve conduction study (NCS) of peroneal motor and sural sensory studies in 60 diabetics with no symptoms of neuropathy. Neurological examination revealed clinical abnormalities suggesting polyneuropathy in 26 patients, 43% of the patients. NCS revealed abnormal values in 63% of the whole patients. Abnormal NCS was confirmed in 88% of the positive sign group. As to the negative sign group 44% had abnormalities in NCS. Prolonged F-wave latency was seen in 29% in no sign group and in 66% of the patients with positive signs. We found close association between neurological deficit score and abnormalities in NCS. Among various parameter of systemic nerve conduction study in subclinical patients, prolonged F-wave latency seems the commonest abnormality suggesting morphological changes in subclinical diabetic nerve. Decrease in amplitude of compound sensory action potential of sural nerve is another earlier abnormality, which is, then, accompanied by a fall in motor amplitude of peroneal nerve in advanced patients. Recently, our own group of Hirosaki has demonstrated that somatosensory central conduction time (CCT) between the spinal cord entry time and the arrival time to the sensory cortex is prolonged in diabetics. This abnormality might be partly responsible for the irreversible sensory deficits of diabetic neuropathy.
authors.affiliation: Department of Neurological Sciences, Hirosaki University School of Medicine, Hirosaki, Japan. masababa@cc.hirosaki-u.ac.jp
authors.forename: M
authors.initials: M
authors.lastname: Baba
authors.forename: I
authors.initials: I
authors.lastname: Ozaki
mesh_terms: D000200:Action Potentials; D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000503:physiopathology; D003929:Diabetic Neuropathies / Q000209:etiology / Q000503:physiopathology*; D005073:Evoked Potentials, Somatosensory; D006801:Humans; D008875:Middle Aged; D009431:Neural Conduction; D009460:Neurologic Examination; D010543:Peroneal Nerve / Q000503:physiopathology*; D010865:Pilot Projects; D013497:Sural Nerve / Q000503:physiopathology*